Wednesday, May 14, 2008

GlaxoSmithKline

GlaxoSmithKline Pharma announced a collaboration with Japan based Astellas Pharma for exclusive rights for the latter`s injectible anit-fungal agent namely, Micafungin in the India market.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)